ABSTRACTS & POSTERS

  • Clinical and immunologic response of patients with advanced solid tumors vaccinated with an optimized cryptic hTERT peptide ASCO 2008 Annual Meeting, abstract  PDF file to downloadA. Kotsakis, K. Vetsika, N. Christou, M. Drogaris, N. Pantazopoulos, D. Aggouraki, G. Konsolakis, K. Kosmatopoulos, D. Mavroudis, V. Georgoulias
  • Immune responses in cancer patients after vaccination with the therapeutic telomerase-specific vaccine Vx-001.99th AACR Annual Meeting (2008), abstract  PDF file to download
    E.K Vetsika, G. Konsolakis, E. Bolonaki, A. Kotsakis, E. Papadimitraki, N. Christou, M. Drogaris, D. Aggouraki, J. Menez-Jamet, K. Kosmatopoulos, V. Georgoulias, D. Mavroudis.
  • Vaccination of patients with advanced non-small cell lung cancer with an optimized hTERT cryptic peptide (Vx-001) ASCO 2007 Annual Meeting , poster  PDF file to download
    Kosmatopoulos K, Bolonaki E, Kotsakis A, Papadimitraki E, Agouraki D, Konsolakis G, Vagia A, Christophylakis Ch, Georgoulias V, Mavroudis D.
  • Safety and Immunogenicity of the Optimized Cryptic Peptide TERT572Y in Patients with Advanced Cancer : Latest Clinical Data.The 97th AACR Annual Meeting (2006), poster PDF file to download
    K. Kosmatopoulos, E. Bolonaki, S. Cornet, E. Nikoloudi, P. Kanellou, G. Millaki, J. Menez, C. Christophilakis, M. Spiropoulou, P. Cordopatis, D. Mavroudis, V. Georgoulias.
  • Safety and immunogenicity of the optimized cryptic peptide TERT572Y in patients with advanced malignancies : a phase I clinical study ASCO 2005 Annual Meeting, poster PDF file to download
    K. Kosmatopoulos, R. Bolonaki, S. Cornet, E. Nikoloudi, P. Kanellou, G. Millaki, I. Miconnet, J. Menez, C. Christophilakis, M. Spiropoulou, V. Georgoulias, D Mavroudis.